Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Tostrex completes European MRP

April 13, 2006

Emisphere expands enrollment in phase II oral insulin trial

April 13, 2006

Promising results seen with denosumab in postmenopausal osteoporosis

April 13, 2006

Quigley to begin clinical studies for QR-333

April 12, 2006

New phase II study begins for GLP-1 agonist AVE-0010

April 12, 2006

AdipoGenix and Unigen to develop plant-based therapeutics that target fat

April 11, 2006

Recent patents report new therapeutic agents for metabolic disorders

April 10, 2006

New agents for treating endocrine-related disorders disclosed in recent patents

April 10, 2006

Kissei licenses rights to novel antidiabetic agent KGA-2727 to GlaxoSmithKline

April 10, 2006

Novel potent fibrate analogues synthesized at Dr. Reddy's

April 7, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 18, 2026.
ASGCT 2026: Directed evolution in gene therapy
BioWorld
Directed evolution has become a central pillar in gene therapy. This engineering strategy enables the generation of more efficient variants of genetic editors and...
Fosun secures rights to Aribio’s AR-1001 in potential $4.7B deal
BioWorld
Shanghai Fosun Pharmaceutical (Group) Co. Ltd. is paying $60 million up front for an option to secure exclusive rights to Aribio Co. Ltd.’s oral phase III-stage...
Biogen AD drug shows tau, cognition benefit, despite trial miss
BioWorld
Biogen Inc. has decided to advance diranersen (BIIB-080) into registrational trials for early Alzheimer’s disease, even though the antisense oligonucleotide...
NTX-819, a novel mGlu7 NAM for psychiatric disorders
BioWorld Science
Increasing evidence supports metabotropic glutamate mGlu7 receptor as a promising target in psychiatric disorders. Neurosterix Pharma Sarl has presented data on...